Historical record - last NADAC publication: 8/18/2021

Product Information

OLOPATADINE HCL 0.2% EYE DROP is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $4.2477 per ML under NDC 62332050203. Its NADAC has been published 71 times since Apr 29, 2020.

OLOPATADINE HCL 0.2% EYE DROP

olopatadine hydrochloride
$4.2477per ML

Strength

2 mg/mL

NDC

62332050203

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Last Updated

8/18/2021

Active Ingredients

OLOPATADINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA209420

On Market Since

4/29/2019

Pharmacological Classes

Decreased Histamine Release
Histamine H1 Receptor Antagonists
Histamine-1 Receptor Inhibitor

Price Statistics

The NADAC for OLOPATADINE HCL 0.2% EYE DROP has been published 71 times since Apr 29, 2020, and over the history we have for it it has declined 26.8%. The table below summarizes its recorded NADAC range and movement.

Current price$4.2477 per ML
All-time high$5.8621 (Jul 14, 2021)
All-time low$4.2477 (Aug 18, 2021)
Median price$5.0379
Average price$5.0475
Largest weekly change-26.6% (Jul 21, 2021)
Weeks tracked71
Tracking sinceApr 29, 2020

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

-27.5%

All

-26.8%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 29% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 29%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of OLOPATADINE HCL 0.2% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for OLOPATADINE HCL 0.2% EYE DROP, manufactured by Alembic Pharmaceuticals Inc., is $4.2477 per ML (NDC 62332050203), effective Sep 1, 2021.

How has the price of OLOPATADINE HCL 0.2% EYE DROP changed over time?

Over the history we have for it, the NADAC for OLOPATADINE HCL 0.2% EYE DROP has declined 26.8%. It has been tracked across 71 weekly CMS publications since Apr 29, 2020.

What are the highest and lowest recorded NADAC prices for OLOPATADINE HCL 0.2% EYE DROP?

Since Apr 29, 2020, the NADAC for OLOPATADINE HCL 0.2% EYE DROP has ranged from a low of $4.2477 (Aug 18, 2021) to a high of $5.8621 (Jul 14, 2021), with a median of $5.0379 per ML.

Are there cheaper alternatives to OLOPATADINE HCL 0.2% EYE DROP?

Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, OLOPATADINE HCL 0.2% EYE DROP, is $2.9954 per ML — about 29% below OLOPATADINE HCL 0.2% EYE DROP.

Who manufactures OLOPATADINE HCL 0.2% EYE DROP?

OLOPATADINE HCL 0.2% EYE DROP (NDC 62332050203) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.